apollo

Select Address

Search Medicines
  • Login
  1. Home
  2. Suregraft 0.25 Tablet

  3. Suregraft 0.25 Tablet Substitute

Suregraft 0.25 Tablet Substitute

Substitutes safety advice
call Doctor

Verified Ingredients and Effects

Composition:

EVEROLIMUS-0.25MG

Uses:

Treatment of Breast cancer, pancreatic cancer, lung cancer and kidney cancer.

Medicinal Benefits:

Suregraft 0.25 Tablet is indicated to the patients dealing with breast cancer, pancreatic cancer, lung cancer, kidney cancer and stomach/ intestinal cancer. Cancer of this type tends to spread quickly in other parts of the body. Suregraft 0.25 Tablet travels through the bloodstream and effectively destroys cancerous cells and other parts of the body. It works by decreases the activity of the immune system of the body and prevents rejection of the transplanted organ. It works by stopping the action of an abnormal protein that causes the multiplication of cancerous cells. In this way, it stops the spread of cancerous cells. Besides this, it is also effective in people with genetic disorders to treat some types of tumors in the brain or kidney.

FAQs

Suregraft 0.25 Tablet is used to treat breast cancer, pancreatic cancer, lung cancer and kidney cancer.

Suregraft 0.25 Tablet is an anticancer medicine. It belongs to a group of medicines known as a kinase inhibitor. It works by lowering the blood supply to the tumor, which reduces the growth and spread of cancer cells.

There is no specific duration of treatment with Suregraft 0.25 Tablet. Suregraft 0.25 Tablet is continued till benefit is seen or undesirable toxicity or side effects occur.

You should prevent grapefruit or grapefruit juice while taking Suregraft 0.25 Tablet. This is because taking them together may rise the levels of Suregraft 0.25 Tablet in your blood to toxic levels. Avoid the use of live vaccinations and any probable contact with people who have received live vaccinations.

Suregraft 0.25 Tablet can lead to serious side effects that consist of severe allergic reactions, angioedema (painless swelling under the skin) and kidney failure which can be dangerous and can lead to death. It is possible that you may develop an infection or problems associated to lungs like breathing problems.

It usually takes three to six months for most types of lung cancer to double their size. It will take a long time for lung cancer to reach a size that could be diagnosed in X-Ray.

Suregraft 0.25 Tablet contains Everolimus, which belongs to the group of medicines known as kinase inhibitors.

Regular monitoring is essential when using Suregraft 0.25 Tablet. Your doctor may check your blood tests, blood sugar, blood pressure, and kidney function. They may also adjust your dose based on your response to treatment or any side effects that occur. It's essential to report any changes or concerns to your doctor to ensure safe and effective treatment.

While taking Suregraft 0.25 Tablet, avoiding certain things is essential to ensure your safety. Avoid consuming grapefruit juice and products and St. John's Wort, as they can interact with the medication. Certain antibiotics, antifungals, and medications can also interact with Everolimus, so consult your doctor before taking any new medications. Additionally, consult your doctor before receiving any vaccinations and avoid high-risk activities that may increase the risk of infections and bleeding. It's also important to avoid getting pregnant or fathering a child while taking Everolimus, as well as breastfeeding. Finally, limit your sun exposure to avoid increasing the risk of skin cancer. Always consult your doctor or pharmacist for a comprehensive list of medications and activities to avoid while taking Everolimus.

Before using any medication, including Suregraft 0.25 Tablet, you should know its purpose, usage, safety profile, precautions, and limitations.

Suregraft 0.25 Tablet is administered orally in the form of a tablet. Take Everolimus with or without food, as advised by your doctor. Swallow the tablet whole with water; do not crush, break, or chew it. Note: It's important to follow your doctor's instructions and take Suregraft 0.25 Tablet exactly as prescribed

By regularly monitoring your progress through brain scans and other evaluations, your doctor can determine if Suregraft 0.25 Tablet is effectively shrinking your brain tumor.

Suregraft 0.25 Tablet is indeed considered a cytotoxic medication, but it's a targeted therapy that specifically targets cancer cells and inhibits their growth. It's not a traditional chemotherapy medication, but it can still have side effects and be harmful to healthy cells to some extent. If you have any concerns or questions, please consult your doctor or healthcare team to discuss potential risks and benefits and manage any side effects.

Common side effects of Suregraft 0.25 Tablet may include weakness, infection, sinus inflammation, cough, diarrhoea, fever, fatigue, otitis media (infection of the ear), stomatitis (Inflammation of the mouth) and upper respiratory tract infection. Most of these side effects of Suregraft 0.25 Tablet do not require medical attention and gradually resolve over time. However, if the side effects persist or worsen, please consult your doctor.